Search results for

It was another bad day for the stock market. The Dow Industrial Average and the S&P 500 both suffered declines of about 2 percent. For the Dow, that translates to a nearly 300-point loss.

In the 1970s, two-year and four-year colleges started replacing full-time faculty with part-time instructors. Since then, disputes over pay, benefits and working conditions for these adjunct instructors have ballooned into big problems on many campuses.

The comments are Christie's first since the Jan. 9 news conference in which said he was "embarrassed and humiliated" that his aides punished the mayor of Fort Lee by closing lanes that lead to the George Washington Bridge. Christie reiterated that he knew nothing about the lane closures.

Google, Yahoo and others said they received thousands of secret-court-approved government requests for their users' content. The companies said only a small percentage of their users were affected by the requests.

Many American food companies, responding to consumer demands, are looking for grain that's not genetically modified. It turns out that non-GMO corn and soybeans aren't hard to find. Years ago, grain traders set up a supply chain to deliver non-GMO grain from U.S. farmers to customers in Japan.

Russell Currier, a native of Stockholm, Maine, earned a spot on the Olympic biathlon team, and that has his hometown abuzz. It's a reward for a region that's spent more than a decade rekindling its Nordic skiing roots.

Also: a new Zadie Smith story; Stephen King will publish a new book; two poems written by David Foster Wallace as a child.

Living with a pet is usually a pleasure, but now and again, it isn't. Fate hands you the wrong animal, but it's youranimal, so what can you do? You try to love it. This tale of a boy and his parrot is a hard case. Even on its way to parrot heaven, it creates trouble.

Michael McFaul led the Obama administration's so-called "reset" of diplomatic relations with the country over the past five years. He says he is leaving to reunite with his family in California.

Drugmakers have been criticized for cost-sharing assistance programs that encourage patients to use brand-name drugs instead of cheaper, generic alternatives. The federal government has frowned on the help, but there are expensive medicines for cancer and rheumatoid arthritis that don't have generic equivalents.